erythropoietin (Serono/Boehringer Man)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameerythropoietin (Serono/Boehringer Man)
Drug Alias Nameerythropoietin
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionHaematopoiesis stimulants
TargetsUpdating
Therapy Area/IndicationsAnemiaHematologic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Serono Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAnemiaHematologic Diseases

Other Information

ATC CodeN/A
Related LinksN/A